On November 25, 2024, Synopsys' Board of Directors approved a change in the company's fiscal year end from a 52/53-week period to October 31 annually. This adjustment aims to enhance the alignment of financial and business processes and streamline reporting.The fiscal year 2024 was a 53-week year, ending on November 2, 2024. The new fiscal year 2025 began on November 3, 2024, and will conclude on October 31, 2025. Consequently, fiscal year 2025 will have eight fewer days compared to fiscal year 2024.Synopsys will not file a transition report, relying on Exchange Act Release No. 26589. This change affects quarterly results, which will now end on January 31, April 30, July 31, and October 31.

On November 25, 2024, Synopsys' Board of Directors approved a change in the company's fiscal year end from a 52/53-week period to October 31 annually. This adjustment aims to enhance the alignment of financial and business processes and streamline reporting.The fiscal year 2024 was a 53-week year, ending on November 2, 2024. The new fiscal year 2025 began on November 3, 2024, and will conclude on October 31, 2025. Consequently, fiscal year 2025 will have eight fewer days compared to fiscal year 2024.Synopsys will not file a transition report, relying on Exchange Act Release No. 26589. This change affects quarterly results, which will now end on January 31, April 30, July 31, and October 31.